2019
DOI: 10.1681/asn.2019010053
|View full text |Cite
|
Sign up to set email alerts
|

Inhibition of Endocytosis of Clathrin-Mediated Angiotensin II Receptor Type 1 in Podocytes Augments Glomerular Injury

Abstract: BackgroundInhibition of the renin-angiotensin system remains a cornerstone in reducing proteinuria and progression of kidney failure, effects believed to be the result of reduction in BP and glomerular hyperfiltration. However, studies have yielded conflicting results on whether podocyte-specific angiotensin II (AngII) signaling directly induces podocyte injury. Previous research has found that after AngII stimulation, β-arrestin–bound angiotensin II receptor type 1 (AT1R) is internalized in a clathrin- and dy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
8
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

3
6

Authors

Journals

citations
Cited by 13 publications
(9 citation statements)
references
References 68 publications
1
8
0
Order By: Relevance
“…Previous studies, including ours, have suggested the importance of the clathrin-mediated endocytic pathway in maintaining the integrity of the glomerular filtration barrier (1,(32)(33)(34)(35). In order to examine the clinical relevance of endocytosis in human disease, we probed a human database, Nephroseq, and discovered that decreased glomerular expression of clathrin-mediated endocytic pathways correlated with the reduction in GFR.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Previous studies, including ours, have suggested the importance of the clathrin-mediated endocytic pathway in maintaining the integrity of the glomerular filtration barrier (1,(32)(33)(34)(35). In order to examine the clinical relevance of endocytosis in human disease, we probed a human database, Nephroseq, and discovered that decreased glomerular expression of clathrin-mediated endocytic pathways correlated with the reduction in GFR.…”
Section: Discussionmentioning
confidence: 99%
“…Administration of calpain-1/-2 inhibitors, or targeted deletion of the calpain-1/-2 heterodimer's common regulatory domain, Capns1, reduced both podocyte injury and damage to the glomerular filtration barrier. Endocytosis can be controlled and triggered by calcium channels at the cell membrane and intracellular calcium concentrations (38,39), suggesting that impairment in endocytosis induced by the loss of Gak, similar to the loss of Dnm1/2 inhibiting angiotensin II receptor type 1 internalization, results in the dysregulation of cytoplasmic calcium homeostasis (32) and following calpain activation, explaining the observed increase. However, it is unclear in our current study whether loss of podocyte-associated Gak directly leads to calpain activation because podocyte injury in itself (37).…”
Section: Discussionmentioning
confidence: 99%
“…In our study, inhibition of Arf6 activity by both secinH3 and Arf6 knockdown dramatically prevented Ang IIinduced caspase 3 activation as well as Nox4 and ROS production, suggesting that elevation of active Arf6-GTP by Ang II is required for Nox4 upregulation and ROS production. Just recently, it has been reported that in dynamin1/2-deficient primary podocytes, Ang II induces abnormal membrane dynamics with increased Rac1 activation and lamellipodial extension, which was attenuated in deficiency of AT1R [32]. This finding suggests that the internalization of AT1R is blunted and Ang II signal is prolonged in podocytes with dynamin1/2 deficiency.…”
Section: Plos Onementioning
confidence: 94%
“…Under physiological circumstances, podocytes heavily rely on CME for maintenance of the slit-diaphragm for internalizing nephrin (5,8) as well as receptors such as the type Ia angiotensin II receptor (9). However, to our knowledge, CCV proteomics to identify CCV-associated proteins have not been elucidated in podocytes.…”
Section: Introductionmentioning
confidence: 99%